Stockley’s Drug Interactions
11th February 2025
Stockley’s Drug Interactions
This update of Stockley’s Drug Interactions consists of 28 new…
Stockley’s Drug Interactions
Practical, evidence-based information to manage drug interactions safely and effectively
Stockley’s Drug Interactions includes concise, accurate, and clinically relevant information on interactions between therapeutic drugs, proprietary medicines, herbal medicines, foodstuffs, drinks, pesticides, and drugs of abuse based on published sources including clinical studies, case reports, and systematic reviews.
Expertly authored, Stockley’s Drug Interactions covers interactions between therapeutic drugs, proprietary medicines, herbal medicines, foodstuffs, drinks, pesticides, and drugs of abuse.
Regularly updated information on drug interactions
Easy access to drug-drug, drug-food or drug-herb interactions
Clinically relevant, evaluated, and evidence-based information
Detailed clinical evidence, explanation of mechanism, and assessment of clinical importance
Clear and practical management guidance
Quick access to multiple interaction records in one place
Includes drugs used worldwide
Intuitive interactions search
Search an unlimited number of drugs at a time
Latest knowledge updates
Our knowledge products are regularly updated online through MedicinesComplete
11th February 2025
Stockley’s Drug Interactions
This update of Stockley’s Drug Interactions consists of 28 new monographs and 126 updated monographs, including updates to the classification tables of drugs that are inducers, inhibitors, and substrates of cytochrome P450 isoenzymes. The monographs on the GLP-1 receptor agonists have been revalidated and updated, and several new drugs have been added including fezolinetant and zuranolone.
Click to close
12th November 2024
Stockley’s Drug Interactions
For this update of Stockley’s Drug Interactions, the classification tables…
12th November 2024
Stockley’s Drug Interactions
For this update of Stockley’s Drug Interactions, the classification tables of drugs transported by or affecting drug transporters have been fully updated against the FDA’s Examples of Drugs that Interact with CYP Enzymes and Transporter Systems 2023. In addition, several new drugs have been added. In total there are 54 new monographs and 159 revised monographs in this update.
Click to close
13th August 2024
Stockley’s Drug Interactions
This update of Stockley’s Drug Interactions consists of 30 new…
13th August 2024
Stockley’s Drug Interactions
This update of Stockley’s Drug Interactions consists of 30 new monographs and 25 updated monographs. New drugs added for this update include: binimetinib, encorafenib, fostamatinib, and tivozanib.
Click to close
14th May 2024
Stockley’s Drug Interactions
This update of Stockley’s Drug Interactions consists of 57 new…
14th May 2024
Stockley’s Drug Interactions
This update of Stockley’s Drug Interactions consists of 57 new monographs and 90 updated monographs, including a review of the effects of ciprofloxacin on CYP3A4. New drugs added for this update include: capmatinib, cenobamate, enasidenib, ganaxolone, olutasidenib, pretomanid, tucatinib, and vonoprazan.
Click to close
13th February 2024
Stockley’s Drug Interactions
This update includes 4 new monographs and 52 updated monographs,…
13th February 2024
Stockley’s Drug Interactions
This update includes 4 new monographs and 52 updated monographs, including changes to Table 9.2: Drugs causing QT prolongation and torsade de pointes.
Click to close
14th November 2023
Stockley’s Drug Interactions
For this update of Stockley’s Drug Interactions there are 94…
14th November 2023
Stockley’s Drug Interactions
For this update of Stockley’s Drug Interactions there are 94 new monographs and there have been updates to 58 existing monographs.
The following drugs have been added: avapritinib, baloxavir marboxil, bictegravir, dacomitinib, erdafitinib, gilteritinib, favipiravir, fedratinib, larotrectinib, lasmiditan, lorlatinib, maribavir, pexidartinib, selumetinib, sotorasib, upadacitinib, vericiguat, and zanubrutinib. In addition, dicloxacillin and flucloxacillin have been reviewed and updated with respect to induction of CYP3A4.
Click to close
Request access today
Access Stockley’s Drug Interactions through MedicinesComplete today.
Contact us now for pricing and access information.
Related resources
Upcoming Webinar
27th February 2025 – 14:00 GMT (14:00 UTC, 09:00 EST)
Navigating rare disease care with MedicinesComplete
Related publications
-
Stockley’s Drug Interactions Twelfth Edition
Access to evidence-based information on drug interactionsExpertly authored advice on managing dr…
Info -
FEATUREDMartindale: The Complete Drug Reference 41st Edition
Unbiased, evaluated information on drugs and medicines in use around the world
Info -
Stockley’s Herbal Medicines Interactions Second Edition
Widely recognized as a trusted and authoritative source of information, enhancing patient safety and…
Info
See all our printed publications in the Shop.
Access the essential knowledge you need today
Opens in a new window